Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients. (Q40154187)
Jump to navigation
Jump to search
scientific article published on December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients. |
scientific article published on December 2007 |
Statements
Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients (English)
Claudia Saracini
Ilaria Sestini
Rosanna Abbate
Serafina Valente
Davide Antoniucci
Gian Franco Gensini
1 December 2007